Get complete access to comprehensive company data for Delexcel Pharma Private Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Delexcel Pharma Private Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 16.00 cr
₹ 10.00 cr
04 Sep 2014
31 Mar 2022
Delexcel Pharma Private Limited is an Indian private limited company incorporated on 04 Sep 2014. The company's registered office is situated in Medak, Telangana, India.
The current status of Delexcel Pharma Private Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2022 (FY 2021-2022).
Delexcel Pharma Private Limited is a company limited by shares with an authorized capital of ₹16.00 cr and a paid-up capital of ₹10.00 cr as per the records maintained by the Ministry of Corporate Affairs (MCA).
Delexcel Pharma Private Limited has 3 directors and 1 signatories. The Key Managerial Personnel (KMP) at Delexcel Pharma Private Limited include Raghupathi Kandarapu as Ceo. The directors of the company include Raghupathi Kandarapu, Madhava Rao Tumati, Venkata Sirisha Tumati.
The registered office of Delexcel Pharma Private Limited is located at Survey No 228/2 228/3, Kucharam Village,Beside Tsiic,Manoharaba D Mandal Medak Telangana 502336 India in Medak, Telangana, India.
- CIN/LLPIN/FCRN: U24232TG2014PTC095535
- Legal Name: Delexcel Pharma Private Limited
- ROC Code: Roc Hyderabad
- Company No.: 095535
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Private
- Listing Status: Unlisted
- Industry: Pharma
- Date of AGM: 30 Sep 2022
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Delexcel Pharma Private Limited |
|---|
Frequently Asked Questions
- madhava rao tumati
- raghupathi kandarapu
- raghupathi kandarapu
- venkata sirisha tumati